Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Phibro Animal Health (PAHC) Accounts Payables: 2013-2025

Historic Accounts Payables for Phibro Animal Health (PAHC) over the last 12 years, with Sep 2025 value amounting to $130.6 million.

  • Phibro Animal Health's Accounts Payables rose 50.93% to $130.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was $130.6 million, marking a year-over-year increase of 50.93%. This contributed to the annual value of $138.2 million for FY2025, which is 61.51% up from last year.
  • Phibro Animal Health's Accounts Payables amounted to $130.6 million in Q3 2025, which was down 5.50% from $138.2 million recorded in Q2 2025.
  • In the past 5 years, Phibro Animal Health's Accounts Payables ranged from a high of $138.2 million in Q2 2025 and a low of $62.8 million during Q1 2021.
  • In the last 3 years, Phibro Animal Health's Accounts Payables had a median value of $86.4 million in 2023 and averaged $97.1 million.
  • In the last 5 years, Phibro Animal Health's Accounts Payables dropped by 22.74% in 2023 and then surged by 61.51% in 2025.
  • Quarterly analysis of 5 years shows Phibro Animal Health's Accounts Payables stood at $80.7 million in 2021, then dropped by 0.22% to $80.5 million in 2022, then increased by 7.36% to $86.4 million in 2023, then climbed by 15.09% to $99.4 million in 2024, then soared by 50.93% to $130.6 million in 2025.
  • Its last three reported values are $130.6 million in Q3 2025, $138.2 million for Q2 2025, and $131.6 million during Q1 2025.